All articles tagged with #early access program
Revolution Medicines has begun shipping its experimental pancreatic cancer drug, daraxonrasib, under an FDA-authorized early-access program after Phase 3 results showed patients lived nearly twice as long as those on standard chemotherapy, fueling high demand ahead of formal FDA approval.
Meta Platforms, the parent company of Facebook, Instagram, WhatsApp, and Oculus VR, is beginning a small trial in the U.S. of a new multimodal AI designed to run on its Ray Ban Meta smart glasses. The new AI, set to launch publicly in 2024, takes advantage of the glasses' camera to provide information about both user queries and the world around them. The glasses currently have a limited voice-controlled AI assistant, but the new multimodal version aims to intelligently respond to video and photography. The trial will be conducted through an early access program, and the glasses are priced at $299.
Microsoft is launching the Microsoft 365 Copilot Early Access Program, allowing 600 organizations worldwide to test its new set of generative AI tools for Microsoft 365. The new AI capabilities will be tested in Office, Teams, Viva, Loop, and more. Microsoft has been testing its new copilot for work with 20 enterprise customers over the past two months. The company is also launching the Semantic Indew Copilot for organizations with a Microsoft 365 E3 and E5 plan. Microsoft 365 Copilot will become generally available after ensuring that customers can trust it.